William S Chen, Winston A Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha, Minlu Zhang, Adam Foye, Ignacio Baselga Carretero, Ivan Perez Garcilazo, Meng Zhang, Shuang G Zhao, Martin Sjöström, David A Quigley, Jonathan Chou, Tomasz M Beer, Matthew Rettig, Martin Gleave, Christopher P Evans, Primo Lara, Kim N Chi, Robert E Reiter, Joshi J Alumkal, Alan Ashworth, Rahul Aggarwal, Eric J Small, Patrick S Daugherty, Antoni Ribas, David Y Oh, John C Shon, Felix Y Feng
PURPOSE: Autoantibody responses in cancer are of great interest, as they may be concordant with T-cell responses to cancer antigens or predictive of response to cancer immunotherapies. Thus, we sought to characterize the antibody landscape of metastatic castration-resistant prostate cancer (mCRPC). EXPERIMENTAL DESIGN: Serum antibody epitope repertoire analysis (SERA) was performed on patient serum to identify tumor-specific neoepitopes. Somatic mutation-specific neoepitopes were investigated by associating serum epitope enrichment scores with whole-genome sequencing results from paired solid tumor metastasis biopsies and germline blood samples...
December 1, 2020: Clinical Cancer Research